{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.666.5.2203",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2016-03-31T01:00:12.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Lantana EH Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2022-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2016-03-31"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2203",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.666.5.2203"
    }
  ],
  "version" : "20160331",
  "name" : "IVTigecycline",
  "title" : "IV Tigecycline",
  "status" : "active",
  "experimental" : false,
  "date" : "2016-03-31T01:00:12-04:00",
  "publisher" : "Lantana EH Steward",
  "jurisdiction" : [
    {
      "extension" : [
        {
          "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
          "valueString" : "UNKNOWN"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This set of values contains medications that are commonly used in an inpatient setting for pneumonia. These medications include intravenous  (IV) Tigecycline that is either specifically mentioned in clinical practice guidelines or is a reasonable therapeutic equivalents.),(Data Element Scope: The intent of this data element is to identify patients who are on active medication therapy. Using the Quality Data Model, this particular element will map to the \"Medication\" category.),(Inclusion Criteria: Include tigecycline drugs given by intravenous route.),(Exclusion Criteria: The drug concepts should be limited to those which are appropriate for human use and available to be prescribed in the United States.  Drugs that take on oral, topical or suppository forms should not be included.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "581531",
            "display" : "tigecycline 50 MG Injection"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:1f5cccfb-035f-4c2c-b17f-40aed174bc90",
    "timestamp" : "2023-06-29T18:10:34-04:00",
    "total" : 1,
    "offset" : 0,
    "parameter" : [
      {
        "name" : "count",
        "valueInteger" : 1000
      },
      {
        "name" : "offset",
        "valueInteger" : 0
      }
    ],
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "06052023",
        "code" : "581531",
        "display" : "tigecycline 50 MG Injection"
      }
    ]
  }
}
